410 related articles for article (PubMed ID: 22635102)
1. The metal theory of Alzheimer's disease.
Bush AI
J Alzheimers Dis; 2013; 33 Suppl 1():S277-81. PubMed ID: 22635102
[TBL] [Abstract][Full Text] [Related]
2. Iron-export ferroxidase activity of β-amyloid precursor protein is inhibited by zinc in Alzheimer's disease.
Duce JA; Tsatsanis A; Cater MA; James SA; Robb E; Wikhe K; Leong SL; Perez K; Johanssen T; Greenough MA; Cho HH; Galatis D; Moir RD; Masters CL; McLean C; Tanzi RE; Cappai R; Barnham KJ; Ciccotosto GD; Rogers JT; Bush AI
Cell; 2010 Sep; 142(6):857-67. PubMed ID: 20817278
[TBL] [Abstract][Full Text] [Related]
3. Metallostasis in Alzheimer's disease.
Ayton S; Lei P; Bush AI
Free Radic Biol Med; 2013 Sep; 62():76-89. PubMed ID: 23142767
[TBL] [Abstract][Full Text] [Related]
4. Metal dyshomeostasis and oxidative stress in Alzheimer's disease.
Greenough MA; Camakaris J; Bush AI
Neurochem Int; 2013 Apr; 62(5):540-55. PubMed ID: 22982299
[TBL] [Abstract][Full Text] [Related]
5. Metals and Alzheimer's disease.
Adlard PA; Bush AI
J Alzheimers Dis; 2006 Nov; 10(2-3):145-63. PubMed ID: 17119284
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein E ablation decreases synaptic vesicular zinc in the brain.
Lee JY; Cho E; Kim TY; Kim DK; Palmiter RD; Volitakis I; Kim JS; Bush AI; Koh JY
Biometals; 2010 Dec; 23(6):1085-95. PubMed ID: 20556483
[TBL] [Abstract][Full Text] [Related]
7. The Role of Presenilin in Protein Trafficking and Degradation-Implications for Metal Homeostasis.
Greenough MA
J Mol Neurosci; 2016 Nov; 60(3):289-297. PubMed ID: 27558108
[TBL] [Abstract][Full Text] [Related]
8. Combined deletions of amyloid precursor protein and amyloid precursor-like protein 2 reveal different effects on mouse brain metal homeostasis.
Needham BE; Ciccotosto GD; Cappai R
Metallomics; 2014 Mar; 6(3):598-603. PubMed ID: 24448592
[TBL] [Abstract][Full Text] [Related]
9. Metal Ions in Alzheimer's Disease: A Key Role or Not?
Liu Y; Nguyen M; Robert A; Meunier B
Acc Chem Res; 2019 Jul; 52(7):2026-2035. PubMed ID: 31274278
[TBL] [Abstract][Full Text] [Related]
10. Cu(II) interaction with amyloid-beta peptide: a review of neuroactive mechanisms in AD brains.
Lin CJ; Huang HC; Jiang ZF
Brain Res Bull; 2010 Jul; 82(5-6):235-42. PubMed ID: 20598459
[TBL] [Abstract][Full Text] [Related]
11. Copper and Alzheimer's Disease.
Mathys ZK; White AR
Adv Neurobiol; 2017; 18():199-216. PubMed ID: 28889269
[TBL] [Abstract][Full Text] [Related]
12. Immunogold labeling and X-ray fluorescence microscopy reveal enrichment ratios of Cu and Zn, metabolism of APP and amyloid-β plaque formation in a mouse model of Alzheimer's disease.
Wang H; Wang M; Wang B; Li M; Chen H; Yu X; Yang K; Chai Z; Zhao Y; Feng W
Metallomics; 2012 Oct; 4(10):1113-8. PubMed ID: 22992540
[TBL] [Abstract][Full Text] [Related]
13. The modulation of metal bio-availability as a therapeutic strategy for the treatment of Alzheimer's disease.
Crouch PJ; White AR; Bush AI
FEBS J; 2007 Aug; 274(15):3775-83. PubMed ID: 17617225
[TBL] [Abstract][Full Text] [Related]
14. The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human beta-amyloid precursor protein transgenic mice.
Lee JY; Friedman JE; Angel I; Kozak A; Koh JY
Neurobiol Aging; 2004; 25(10):1315-21. PubMed ID: 15465629
[TBL] [Abstract][Full Text] [Related]
15. Effect of cerebral amyloid angiopathy on brain iron, copper, and zinc in Alzheimer's disease.
Schrag M; Crofton A; Zabel M; Jiffry A; Kirsch D; Dickson A; Mao XW; Vinters HV; Domaille DW; Chang CJ; Kirsch W
J Alzheimers Dis; 2011; 24(1):137-49. PubMed ID: 21187585
[TBL] [Abstract][Full Text] [Related]
16. Alzheimer's disease and amyloid: culprit or coincidence?
Skaper SD
Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
[TBL] [Abstract][Full Text] [Related]
17. Interactions of Zn(II) and Cu(II) ions with Alzheimer's amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity.
Tõugu V; Tiiman A; Palumaa P
Metallomics; 2011 Mar; 3(3):250-61. PubMed ID: 21359283
[TBL] [Abstract][Full Text] [Related]
18. Aluminum, copper, iron and zinc differentially alter amyloid-Aβ(1-42) aggregation and toxicity.
Bolognin S; Messori L; Drago D; Gabbiani C; Cendron L; Zatta P
Int J Biochem Cell Biol; 2011 Jun; 43(6):877-85. PubMed ID: 21376832
[TBL] [Abstract][Full Text] [Related]
19. Clioquinol reduces zinc accumulation in neuritic plaques and inhibits the amyloidogenic pathway in AβPP/PS1 transgenic mouse brain.
Wang T; Wang CY; Shan ZY; Teng WP; Wang ZY
J Alzheimers Dis; 2012; 29(3):549-59. PubMed ID: 22269164
[TBL] [Abstract][Full Text] [Related]
20. Copper and Alzheimer's disease.
Donnelly PS; Xiao Z; Wedd AG
Curr Opin Chem Biol; 2007 Apr; 11(2):128-33. PubMed ID: 17300982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
